LBF20207PG43: Difference between revisions
No edit summary |
No edit summary |
||
Line 11: | Line 11: | ||
|Chemical Synthesis= | |Chemical Synthesis= | ||
|Metabolism= | |Metabolism= | ||
|Biological Activity=8-iso PGE2 inhibits U-46619 or I-BOP-induced platelet aggregation with IC50 values of 0.5 and 5 <FONT FACE="Symbol">m</FONT>M.[[Reference:Longmire_AW:Roberts_LJ:Morrow_JD:,Prostaglandins,1994,48,247|{{RelationTable/GetFirstAuthor|Reference:Longmire_AW:Roberts_LJ:Morrow_JD:,Prostaglandins,1994,48,247}}]] 8-iso PGE2 is also reported to decrease 80% of the GFR and renal plasma flow without affecting blood pressure in infusing into the renal artery of rats.[[Reference:Pace-Asciak_C:,J. Am. Chem. Soc.,1976,98,2348|{{RelationTable/GetFirstAuthor|Reference:Pace-Asciak_C:,J. Am. Chem. Soc.,1976,98,2348}}]] | |||
}} | }} | ||
{{Lipid/Footer}} | {{Lipid/Footer}} |
Revision as of 06:00, 7 January 2010
LipidBank Top (トップ) |
Fatty acid (脂肪酸) |
Glycerolipid (グリセロ脂質) |
Sphingolipid (スフィンゴ脂質) |
Journals (雑誌一覧) |
How to edit (ページの書き方) |
IDs and Links | |
---|---|
LipidBank | XPR1780 |
LipidMaps | - |
CAS | |
KEGG | {{{KEGG}}} |
KNApSAcK | {{{KNApSAcK}}} |
mol | LBF20207PG43 |
8-iso Prostaglandin E2 | |
---|---|
Structural Information | |
9-oxo-11a,15S-dihydroxy- (8b) -prosta-5Z,13E-dien-1-oic acid | |
| |
Formula | C20H32O5 |
Exact Mass | 352.224974134 |
Average Mass | 352.46508 |
SMILES | C(CC[C@H](O)C=C[C@H]([C@@H]1CC=CCCCC(O)=O)[C@@H](CC1=O)O)CC |
Physicochemical Information | |
8-iso PGE2 inhibits U-46619 or I-BOP-induced platelet aggregation with IC50 values of 0.5 and 5 mM. Longmire_AW et al. 8-iso PGE2 is also reported to decrease 80% of the GFR and renal plasma flow without affecting blood pressure in infusing into the renal artery of rats. Pace-Asciak_C | |
Spectral Information | |
Mass Spectra | |
UV Spectra | |
IR Spectra | |
NMR Spectra | |
Other Spectra | |
Chromatograms |
Reported Metabolites, References | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
|